4//SEC Filing
Sabag Mark 4
Accession 0000950170-25-021151
CIK 0000818686other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:03 PM ET
Size
5.3 KB
Accession
0000950170-25-021151
Insider Transaction Report
Form 4
Sabag Mark
See "Remarks"
Transactions
- Sale
Ordinary Shares
2025-02-12$16.25/sh−177,626$2,886,565→ 204,964 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.335, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001721442
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:03 PM ET
- Size
- 5.3 KB